Baliopharm AG

Baliopharm AG, as part of the Promethera Biosciences Group, is a biotechnology company focusing on the development of innovative and cell-based therapeutics for the treatment of chronic liver diseases, immune mediated inflammatory diseases, as well as for cancer. Baliopharm's portfolio consists of monoclonal antibodies and antibody derived proteins like monovalent formats and bispecifics, which leads to unique target selectivity.